학술논문
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
Document Type
Article
Author
Fan, Xiaohong; Dai, Xiahong; Ling, Yun; Wu, Lihua; Tang, Lingling; Peng, Chunxian; Huang, Chaolin; Liu, Hongyan; Lu, Hongzhou; Shen, Xinghua; Zhang, Wei; Wang, Furong; Li, Guangming; Li, Ming; Huang, Yanming; Zhang, Hongying; Li, Minghui; Ren, Fei; Li, Yuanyuan; Liu, Chenfan; Zhou, Zhiguo; Sun, Wei; Yi, Yongxiang; Zhou, Daming; Gao, Hainv; Pan, Qi; Liu, Hongde; Zhao, Jiang; Ding, Zhen; Ma, Yingmin; Li, Wei; Wang, Quanhong; Wang, Xicheng; Bai, Yichun; Jiang, Xiangao; Ma, Juan; Xie, Bingying; Zhang, Kui; Li, Lanjuan
Source
In The Lancet Infectious Diseases February 2024 24(2):129-139
Subject
Language
ISSN
1473-3099